Franklin Resources
MAZE

Franklin Resources’s Maze Therapeutics MAZE Stock Holding History

Franklin Resources’s Portfolio MAZE Stock Details MAZE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.39M Buy
80,216
+20,579
+35% +$539K ﹤0.01% 1931
2026
Q1 		$1.78M Buy
59,637
+4,408
+8% +$195K ﹤0.01% 1948
2025
Q4 		$2.29M Buy
55,229
+37,031
+203% +$1.27M ﹤0.01% 1722
2025
Q3 		$472K Buy
+18,198
New +$307K ﹤0.01% 2454

Other funds holding MAZE

FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
TGI
TRV GP IV Boston, Massachusetts $254M AUM 426.76% 1-Year Est. Return
AVM
Arch Venture Management Chicago, Illinois $1.1B AUM 356.62% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
ACM
AH Capital Management Menlo Park, California $14.2B AUM 20.01% 1-Year Est. Return

Franklin Resources's MAZE Position: Q2 2026 in Review

Franklin Resources increased its Maze Therapeutics (MAZE) stake by 35% in Q2 2026, buying an estimated $539K and bringing the position to 80,216 shares worth $2.39M. The position accounts for ﹤0.01% of the portfolio, ranked #1931.

Franklin Resources first reported a position in MAZE in Q3 2025 and has held it in 4 quarters since. 162 funds tracked by Wall St. Rank hold MAZE as of Q2 2026.

  • Franklin Resources held 80,216 shares of Maze Therapeutics worth $2.39M as of Q2 2026.
  • Franklin Resources bought 20,579 Maze Therapeutics shares in Q2 2026, an estimated $539K.
  • Maze Therapeutics made up ﹤0.01% of Franklin Resources's portfolio in Q2 2026, its #1931 holding.
  • Franklin Resources first reported a position in Maze Therapeutics in Q3 2025 and has held it in 4 quarters since.
  • 162 funds tracked by Wall St. Rank held Maze Therapeutics as of Q2 2026.

Based on Franklin Resources's 13F filing for Q2 2026, filed 13 Aug 2026.